HIM
ABMD

Hillsdale Investment Management’s Abiomed Inc ABMD Stock Holding History

Hillsdale Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,300
Closed -$371K – 684
2019
Q1 		$371K Buy
1,300
+200
+18% +$66.5K 0.03% 368
2018
Q4 		$358K Buy
+1,100
New +$382K 0.04% 351

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Hillsdale Investment Management's ABMD Position: Q2 2019 in Review

Hillsdale Investment Management sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 1,300 shares — an estimated $371K sold.

Hillsdale Investment Management first reported a position in ABMD in Q4 2018 and held it in 2 quarters. The position peaked at $371K in Q1 2019. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Hillsdale Investment Management reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,300 Abiomed Inc shares in Q2 2019, an estimated $371K.
  • Hillsdale Investment Management first reported a position in Abiomed Inc in Q4 2018 and held it in 2 quarters.
  • Hillsdale Investment Management's Abiomed Inc position peaked at $371K in Q1 2019.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Hillsdale Investment Management's 13F filing for Q2 2019, filed 2 Aug 2019.